GleamWall
中文EN

NIVF NewGenIvf Group Ltd Annual reports only

Services-Misc Health & Allied Services, NEC · Nasdaq · SEC CIK 1981662

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-13.0%
TTM net income YoY1,983.1%
TTM EPS YoY100.1%
Revenue 3-yr CAGR-7.4%
Net income 3-yr CAGR178.2%

Margins

Gross margin20.2%
Operating margin-226.9%
Net margin209.0%
FCF margin-234.0%
EBITDA margin-223.0%

Returns

ROE77.2%
ROA54.4%
ROIC (approx.)-88.0%
Asset turnover0.26x

Leverage & solvency

Liabilities / assets20.6%
Debt / equity0.00x
Current ratio3.12x
Interest coverage-17.40x

Cash quality & payout

Operating cash flow / net income-1.11x
Accruals ratio114.6%
Payout ratio—
Capex / revenue2.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$4.73M$5.43M
Cost of revenue$3.77M$3.61M
Gross profit$955,846$1.83M
SG&A expense$10.49M$2.78M
Operating income-$10.73M-$1.16M
Interest expense$616,423$765,177
Pretax income$9.73M-$960,807
Income tax—-$486,706
Net income$9.88M-$524,643
EBITDA-$10.54M-$1.14M
EPS (basic)214.73-4,408.76
EPS (diluted)3.04-4,408.76
Weighted avg. shares (diluted)3.25M119
Banking
Provision for credit losses—$17,818
Balance sheet
Cash & equivalents$758,621$457,740
Receivables$166,531$49,245
Inventory$335,360$80,813
Current assets$7.38M$3.17M
PP&E, net$1.79M$273,096
Intangibles$21.42M—
Total assets$32.72M$3.58M
Current liabilities$2.37M$2.72M
Total liabilities$6.74M$5.06M
Shareholders' equity$26.63M-$1.05M
Shares outstanding240,622380
Cash flow statement
Operating cash flow-$10.93M-$8.26M
Capital expenditure$135,025$53,045
Free cash flow-$11.06M-$8.32M
Investing cash flow-$7.56M-$53,045
Financing cash flow$18.99M$8.68M
Depreciation & amortization$188,109$19,502

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.